Status:
UNKNOWN
Soy Peptide, Conjugated Linoleic Acid, Overweight or Obese, Body Composition
Lead Sponsor:
Fangfang Zeng
Collaborating Sponsors:
First Affiliated Hospital, Sun Yat-Sen University
Conditions:
Overweight or Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Soybean peptides are a mixture of active peptides obtained from the hydrolysis of soybean protein, which have biological activities such as antioxidant, blood pressure lowering, anti-fatigue and lipid...
Detailed Description
Aim 1: To test the effects of combined supplementation of soybean peptide and conjugated linoleic acid on body fat, liver fat and muscle content of overweight and obese people;Aim 2: To test the effec...
Eligibility Criteria
Inclusion
- Age - 18-65 years old;
- Gender-not limited;
- BMI-24-35 kg/m2;
- Body fat rate-Male ≥25%, female ≥30% (body fat meter can be used for screening, DXA is used for diagnosis);
- Waist circumference: male \>90cm, Female\>80cm (not required).
Exclusion
- Suffer from serious diseases such as heart, liver, kidney, brain, hematopoietic, immune, thyroid, malignant tumors;
- Take drugs or supplements that have a known effect on body fat and muscle mass;
- Those whose weight has changed more than 10% in the past 3 months;
- Those who have cognitive or mental disorders and cannot conduct questionnaire surveys;
- People who are physically disabled and cannot walk normally;
- Those whose compliance with the pre-experiment period cannot meet the requirements;
- Fail to sign the informed consent form, or other researchers think it is not suitable for participants
Key Trial Info
Start Date :
May 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04728399
Start Date
May 14 2021
End Date
December 20 2022
Last Update
June 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinan University
Guangzhou, Guangdong, China, 457